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Dengue, a mosquito-borne viral disease, poses a global threat owing
to the unavailability of any specific therapeutics. Since prevention is
only restricted to vector control, a clear understanding of Dengue
Virus (DENV) transmission within an infected host is essential. The
dynamics of DENV transmission addressed in light of molecular
communication paradigm is promising in providing crucial infor-
mation accounting for disease control that can lead to development
of novel approaches to clear the virus infection. In this work, we
model the DENV transmission inside the body from the point of a
mosquito bite to the targeted organs as a communication system.
Based on the physiological processes involved in the transmission
of DENV through the layers of skin and vascular systems, we iden-
tify and propose a channel model. By considering the dynamics of
virus transmission through the channel, we analyze and calculate
different channel phenomena, such as path loss and channel noise,
and obtain an analytical expression for the capacity of the proposed
channel model. The uncertainty in signal transmission is modeled
and evaluated owing to the innate and adaptive immune response
in the channel. We performed in-silico experiments for validation
and provided numerical analysis for the channel characteristics. Our
analysis revealed that the attenuation offered in the cutaneous chan-
nel does not result in significant signal loss. We also observed that
the variations in the channel capacity is not substantially affected
by the injection probabilities of the virus.
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1 INTRODUCTION
Nanomedicine provides a platform for significant development in
disease monitoring, in-vivo drug delivery, therapeutic and diagnostic
techniques, and can be realized via nano-networking and molecu-
lar communication. Dengue is one of the globally recognized crit-
ical and threatening diseases due to its pandemic nature in recent
decades. It is an Aedes mosquito-borne infection transmitted to hu-
mans by Dengue virus DENV belonging to the Flaviviridae family.
Dengue spread by five different serotypes, DENV-1, DENV-2, DENV-
3, DENV-4, and DENV-5 from the virus family. These serotypes are
antigenically distinct and produce a unique immune response to the
infection in the host body. DENV approximately infects around 50
million people world-wide per year [1]. The core of Dengue virus is a
positive single-stranded RNA genome inside a protein, encapsulated
by a lipid envelope. The genome functions as mRNA (Messenger
RNA) and conveys genetic information fromDNA to any cell via vesi-
cles for genome synthesis. The spread of multiple dengue serotypes
from one organism to another increases the plausibility of genetic
transformation. These RNA viruses have higher genetic recombina-
tion rate leading to the emergence of new virus serotype [2]. The
continuous process of concurrent infections with distinct dengue
virus serotypes and genetic transformations over the years has lead
to novel challenges in dengue control. The developed dengue vaccine
is effective only when it provides immunity against all the infectious
variants of dengue serotype.
Currently, the vaccine available to treat dengue infection is not
effective as the immunity against one serotype does not protect the
host from other four serotypes. Moreover, being immune to one
virus serotype while subsequently getting infected with another
serotype triggers even more critical disease manifestations [3]. Also,
a seronegative individual getting the vaccine for immunization de-
velops a risk for subsequent severe dengue infection. According to
WHO, a prior screening test and surveillance of infections from simi-
lar virus family is recommended before reaching out for vaccination
[4]. Even if a vaccine is likely to be immunogenic to all the five
serotypes identified, it may not be able to offer immunity against
additional DENV serotypes which are in mutation cycle. The further
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discovery of such serotype would raise risk in the available dengue
vaccine. The ever-increasing mortality rate due to the spread of in-
fectious diseases has evoked the exigency for early identification as
well as the progression of the illnesses. By recognizing the etiology
of dengue fever, and the plausible steps involved in its pathogenesis,
the early detection of the critical disease is possible. DENV plays a
diverse role in the clinical manifestations. Since vaccination is yet
not an effective tool to combat dengue, identifying the pathways
of circulating virus serves to be beneficial. Moreover, detecting the
underlying mechanisms leading to DENV infection aids in under-
standing the disease and its pathology. This would assist in accurate
diagnosis, developing methods to counteract dengue, and producing
an antiviral drug.
An essential question is whether we canmodel the propagation be-
havior of DENV, and in particular its impact as it propagates through
various sub-systems of the human body. In this paper, we propose the
use of molecular communication to model the propagation behavior
of DENV inside a human body. We aim to define the propagation
behavior through the use of communication metrics, such as an ana-
lytical channel model that can establish the propagation from the
skin to the cellular compartments or organs. Based on the spread of
the virus along different paths and limitations faced by the immune
system, we derive the path loss model. Our molecular communica-
tion model links the spreading of the virus to the signal transmission,
where the immune response is abstracted as the attenuation induced
during transmission, while the target sites serve as the receiver.
Our work provides new insight into the propagation behavior of
dengue virus infection, thereby, assisting biopharmaceutical indus-
tries in designing more efficient drugs or tools that can target specific
vulnerable locations that the virus may be located. The following
list constitutes the major research contributions of this paper:
• Modeling dengue transmission as an end-to-end abstraction of
molecular communication channel: We propose a communi-
cation channel model for DENV transmission. The proposed
channel model maps biological processes to major elements
of a communication system. We evaluated the channel based
on biomolecular kinetic processes.
• Determining the influence of the channel on signal transmission:
We characterize a path loss model for signal transmission
based on the effect of the host’s physiological response. We
also approximate a noise model for the channel.
• Evaluating information theoretic-analysis of the channel: We
analytically evaluate the capacity of the channel obtaining
the expression for channel transition probabilities. Since the
propagation of DENV to transport its internal RNA molecules
to infect the host cell is equivalent to carrying information to
the destination cell, we analyze the capacity of information
transport.
2 RELATEDWORK
Major efforts in the closely related area of DENV transmission are
focused on the epidemiological models of disease transmission in
human and vector populations. The relatively few works towards
dengue infection considered monocytes as the only target for in-
fection [5], while assuming constant production rates for the same.
However, it is observed that varying rate of monocyte production
Figure 1: Overview of molecular communication model for
DENV transmission.
contributes to viral infection [6]. Few other works considered role
of antibodies [7] and antiviral therapy [8] during viral infection.
Recent attempts in exploring dengue infection typically deal with
the aspects of virology and immunology. Our work is distinct with
respect to modeling virus transmission as a communication system
using concepts from molecular communication. Few works related
to drug delivery systems model the channel through the molecular
communication paradigm [9, 10]. The proposed model maps the
physiological and bio-molecular processes into the communication
elements. We develop the channel model to identify the dynamics in
signal transmission towards multiple receivers and characterize the
channel.
3 DENV TRANSMISSION MODEL
Wemodel the transmission of DENV within a host body as a commu-
nication system. The source for the signal of the system is generated
when the female mosquito bites and infects the human body. By
using the direct cell-to-cell transmission strategy, DENV propagates
through the cells and vascular network to the blood cells, and reaches
various organs. The pathogenesis of dengue modeled as a communi-
cation systemwhich is shown in Fig. 1, broadly includes the following
communication elements:
• Transmitter: It represents the proboscis of the infected fe-
male mosquito containing dengue virus along with the saliva
that enter the skin in search of blood. The common source
for signal transmission in our conceptualized system is the
point when the mosquito bites the skin of a human and in-
jects the virus into the body. We assume only one serotype
of dengue virus is injected. The source signal, denoted by
V (t ), composed of three distinct virulence of the serotype,
In Vivo Channel Characterization for Dengue Virus Infection NANOCOM ’19, September 25–27, 2019, Dublin, Ireland
Figure 2: Block diagram of communication system representing DENV transmission.
which is partitioned into three mutually exclusive sets,V (t ) =
Vim (t ) ∪ Vpm (t ) ∪ Vf m (t ) representing immature, partially
mature and fully mature virus, respectively, which differs
from each other based on their maturation level. TheVim and
Vpm fuses into the host cells to undergo subsequent steps of
maturation and cleaving to transform into a Vf m . Typically,
during each mosquito bite, around 104 to 106 of virus particles
capable of infection gets injected into the host body [11].
• Channel: During several biting by the mosquito, majority of
virus escapes into the epidermis and dermis layers of the skin,
while relatively small amount of virus reaches the bloodstream
[1]. Thus the channel can be categorised into two subchannels:
(1) Cutaneous, which consists of the epidermis and dermis
layers of the skin cells and (2) Vascular, which consists of
blood vessels for signal transmission.
• Receiver: It is the set of sites such as, lymph nodes, bone mar-
row, and organs (liver, spleen, and lung) [12], which receives
the virus and gets affected with dengue. In this model, the
strength of the signal at the receiver is defined as the time-
varying number of virus particles present within the multiple
receivers.
The DENV transmission in human body is abstracted as a communi-
cation model as conceptualized in Fig. 2. The abstracted processes
are further discussed in detail in following subsections.
3.1 Channel Modeling
The modeled communication channel is categorised into two sub-
channels. A proportion of the transmitted signal, V c goes into the
cutaneous channel whereas the remaining of it Vv goes into the
vascular channel. Both the proportions from the source signal V are
transmitted simultaneously over the subchannels. A part of the trans-
mitted signal along the cutaneous channel escapes into the vascular
channel after maturation. The signals from both the subchannels
are multiplexed in the bloodstream before it reaches the multiple
receivers.
(1) Cutaneous Channel: Typically, consists of Langerhans Cells
(LCs) and Epithelial Cells (ECs) from the epidermis while the Den-
dritic Cells (DCs), tissue Macrophages (MPs), Mast Cells (MCs), and
fibroblasts in dermis for cutaneous route of signal transmission [12].
(2) Vascular Channel: The vascular route consists of interconnected
blood and lymph vessels which includes the lymphocytes, monocytes,
and macrophages of WBC, and platelets to transmit signal [12, 13].
Since only selective mature virus has the ability to invade and
replicate inside host cells, the transmitted signal propagating over
both the subchannels undergo three major processes –maturation,
ligand-receptor binding and replication of virus.
3.1.1 Maturation. The transmitter transmits a set of information
particles {Vim ,Vpm ,Vf m } into the channel. Along the channel, the
immature and partially mature virus particles convert to fully mature
virus particles in furin-dependent environment. We consider the
immature virus convert into partial mature with a rate of δim and
eliminated with a phagocytic rate ρim . In a similar manner, the
partially mature virus convert and eliminate with rates δpm and
ρpm , respectively whereas the mature virus is transmitted along the
channel. Thus, the maturation of virus in channel is quantified with
the following differential equation:
dVim
dt
=  .Vim − (δim + ρim )Vim (1)
dVpm
dt
=  .Vpm + δimVim − (δpm + ρpm )Vpm (2)
dVf m
dt
=  .Vf m + δpmVpm − ρf mVf m (3)
where  . is the virus injection rate and ρf m is the elimination rate
of Vf m via phagocytosis.
3.1.2 Ligand-receptor binding. The virus is passed through the chan-
nel only when it get access to the host cell via binding. For a virus
particle to enter into the intracellular environment, the particle’s
ligands must bind to the surface receptors of host cell. Thus, binding
can be abstracted as filtering, following which the particles enter
into the host via endocytosis and initiate replication. The process
is majorly influenced by recognition and attachment between viral
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surface ligand and cellular surface receptor molecules which are usu-
ally electrostatic in nature. The overall process is facilitated by the
factors such as the number of virus ligands nl , number of receptors
nr , and binding rate r . The ligand-receptor interaction is basically
the intermolecular attraction exploited by the biomolecular kinetics,




= rnl (nr − nc ) (4)
The binding site where the ligand-receptor comes into physical con-
tact is referred to as the interface. This interface often witnesses
defensive strategies, such as the random fluctuation in density of the
fluidic environment characterized by Gaussian noise triggering the
receptor diffusion. By incorporating the noise model [14], the effec-
tive number of receptors is given as nr (t ) = n̄r + σξ (t ), where n̄r is
the average number of receptors, σ 2 is the noise intensity, and ξ (t )
is the Gaussian noise. The number of receptors nr fluctuates at the
interface due to diffusion, thus effecting adversely in the formation
of complexes. To account for these noisy effects on the binding, we
model nc utilizing the noise in Eq. (4) as follows:
dnc (t ) = rnl (n̄r + σξ (t ) − nc (t ))dt − Drnc (t )dt (5)
whereDr corresponds to the receptor diffusion coefficient. Rewriting
Eq. (5) in the differential form, we get the stochastic differential
equation as:
dnc (t ) = rnl (n̄r − nc (t ))dt − Drnc (t )dt
+rnlσξ (t )dt
(6)
where Gaussian noise being stationary has the mean term, ξ (t ) = 0.
By solving Eq. (6) the solution is obtained as follows:




{rnl n̄r + rnlσξ (u)}
e (rnl+Dr )udu
(7)
3.1.3 Replication of virus. The endocytosis and replication of V ,
which producesmore virus offsprings, are speculated as amplification
of the signal. After entering into the host cell, Vf m fuses with the
endosomal membrane releasing its nucleocapsid containing single-
stranded RNA into the cytoplasm. Following a series of steps at the
endoplasmic reticulum (ER), the viral RNA is replicated, amplified,
and formed into numerous Vim to appear on the ER surface. These
are then transported into the trans-Golgi network to release Vf m
thereby amplifying the signal [15]. At time t = 0, considering the
closed group of N number of cells at the target site, Nsc denotes the
number of cells susceptible to receive the virus, while Nic are the
cells already invaded by the virus. We assume there is no further
virus injection from outside into the closed group during the course
of virus transmission. In an interacting environment, the population
growth ofVf m and Nsc forms a backdrop for the predator-prey model
[16]. Considering susceptible host cells Nsc as the prey and mature
virus particlesVf m as the predator, the corresponding densities after
amplication is modeled as:
dNsc
dt









+ γNscVf m − dVf m (9)
where α represents the growth rate of the susceptible host cells
in the absence of virus particles, β denotes the transition rate from
susceptible cells to infected cells, andφ stands for predation rate upon
prey. The transition rate determined by the probability of successful
binding is β = P (b). The parameter ve denotes the engulfing or
endocytic rate, and Ce represents the engulfing capacity of the host
cell given the fact that diameter of the host cell is in µm while that of
a virus particle is in nm, and the time t is measured in microseconds.
Theγ represents the growth rate ofVf m inside the host cell depicting
the amplification (virus replication) rate and d be its (predator) death
rate. The transmission of DENV in the channels do not follow an
entry-exit route from any cell; rather it scatters to the neighboring
cells following a lateral transmission [11]. The virus particles replicate
and undergo maturation inside the host cells, and newly formed
virus cells are released, which infects the nearby cells. The lateral
spread of infection accounts for the bandwidth of the signal. Thus
the bandwidth is determined by the number of infected cells Nic in
the channel at time t . Thus the signal bandwidth can be obtained
from the following equation:
dNic
dt
= rVf mNsc − κNic (10)
where r denotes the ligand-receptor binding rate while κ represents
the rate at which the infected cells die.
3.2 Noise Characterization
It has been observed that vitamin D synthesis in cutaneous envi-
ronment modulates immune response, decreasing the number of
virus transmitted [17] thereby reducing the signal strength. In our
model, the modulation of immune response is characterized as the
noise factor that adds uncertainity to the propagation of signal. The
signal is lost in the channel and do not reach the receivers. We thus
consider Additive white Gaussian noise (AWGN) N(t ) to model the
propagation noise. Thus the rate of signal propagation affected by
noise along the channel is expressed as:
dNic
dt
= rVf mNsc − κNic + N(t ) (11)
where N(t ) ∼ N (0,σ 2v ) and σ 2v is the noise intensity.
3.3 Path Loss
3.3.1 Path Loss in Cutaneous Channel. DENV reaches several re-
ceiver sites through the bloodstream by utilizing the two channels
discussed above. The propagation from the skin to the different re-
ceivers witnesses the immune system at each stage triggered by the
cells. The path loss is abstracted as the loss of virus particles due to
the immune response during the propagation along the channel. As
the virus invades, the surface receptors produce antigens over the
host cells marking the presence of virus particles, which in response
triggers the innate immune response in the cutaneous channel. The
path loss in the cutaneous channel is due to the innate immune
response triggered with the production of signaling proteins such
as interferons (IFNs) by LCs, chemokines by MCs, and cytokines by
the ECs within few hours of infection [15, 18]. The innate attenua-
tion (Ai ) dynamics takes into account production and death rates
of immune proteins that mediate the adaptive cellular attenuation
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Acel modeled as follows:
dAi
dt
= aiNsc − icAiAcel − arAi − (Vim +Vpm ) (12)
where ai is the attenuation rate of virus particles depicting the rate
of production of immune proteins, ic represents the production rate
of immune cells activated by immune proteins, and ar is the removal
rate of the immune proteins.
3.3.2 Path Loss in Vascular Channel. The increase in innate attenu-
ation activating the adaptive (cellular and humoral) immune system
allows for pertinacious attenuation toVf m transmission. The cascade
of the immune response in the dermal cells stimulates cellular re-
sponse (mediated by T cells, B cells, and natural killer (NK) cells) [15]
as well as humoral response (mediated by antibodies) [19] account-
ing for the path loss in the vascular channel. For cellular attenuation
(Acel ), we assume the decay rate to be negligible pertaining to the
cytokine storm resulting in abnormal proliferation of attenuation.
dAcel
dt
= icAiAcel + acNsc − (Vim +Vpm ) (13)
where ac represents proliferation rate of immune cells. Upon acti-
vation of immune response around the cells, the fusion of Vim and
Vpm into the host cells gets hindered, which is rendered by the term
Vim +Vpm in Eqs. (12) and (13). The attenuation originating from
humoral response (Ahmr ) is modeled as follows:
dAhmr
dt
= (η − ηth )Nsc −AhmrNic −AhmrVf m (14)
whereη andηth denotes the production rate of antibodies and thresh-
old parameter that the antibodies must exceed to attenuate the virus.
In this case, the factor AhmrVf m accounts for the clearance rate
of antibodies by the virus. Thus the total path loss in the vascular
channel, which is abstracted through a diffusion model in a fluidic
medium is obtained as Av = Acel +Ahmr .
4 CAPACITY ANALYSIS
In the modeled channel, the transmitter injects virus V consisting
of three symbols represented as {Vim ,Vpm ,Vf m }, whereas the virus
O received by the receiver consists of two symbols represented as
{Opm ,Of m }, where im, pm, and f m refers to the immature, par-
tially mature, and fully mature virus particles, as shown in Fig. 3.
We consider the virus symbols at the transmitter are injected with
probabilities pi , pp , and pf , respectively. The transition probabilities
p (Opm |Vpm ) and p (Of m |Vf m ) are denoted as p21 and p32 respec-
tively, whereas p (Opm |Vim ), p (Of m |Vim ) and p (Of m |Vpm ) are the
transition error probabilities, which are denoted as p11, p12, and p22,
respectively.
Figure 3: Block diagram of DENV transmission through chan-
nel.
Figure 4: State transition diagram.
While traversing the channel, the immature virus particles un-
dergo maturation, and therefore, they cannot be found at the receiver
end. Hence, there are two symbols at the output of the channel:Opm
and Of m . Since the fully mature virus particles do not undergo any
maturation, the transition probability p (Of m |Vf m ) is p32 = 1. The
dynamics of virus maturity is broadly described by the three major
states characterized by – immaturation, partially maturation and
fully maturation. The partially mature and fully mature virus is de-
termined by the presence of uncleaved prM (pre-membrane) protein
in the former, while cleaved prM in the latter [20]. We consider the
dynamics of virus maturity to be represented as a continuous-time
discrete-state Markov process with the aforementioned three states,
which are denoted as S1, S2, and S3. The state transition probabilities
between the states are denoted as a12, a13, a22, and a23, which are
shown in Fig. 4. In state S1, the immature virus particles fuse with the
cell membrane with the rate δf n and enter into the host cells in order
to undergo maturation. The states S2 and S3 represent the partially
maturation and fully maturation of the virus particles, respectively.
Thus, we can map the state transition probabilities into the channel’s
transition error probabilities as a12 = p11, a13 = p12, a22 = p21,
and a23 = p22. The state transition probabilities p11 and p22 can be
obtained from the transition rates for the influx and outflux of Vim ,
Vpm , and Vf m [21] which is given as follows:
p11 =
δim






where δim and δpm are the conversion rates from S1 to S2 and from S2
to S3, respectively. The rates δim and δpm corresponds to the transi-
tion rate as discussed in Section 3.1.1. By using the above description
of the channel, we get the joint symbol probabilities p (Vj ,Ok ) as:
P (Vim ,Opm ) = p11pi , P (Vim ,Of m ) = (1 − p11)pi P (Vpm ,Opm ) =
(1 − p22)pp , P (Vpm ,Of m ) = p22pp , and P (Vf m ,Of m ) = pf where
j ∈ {im,pm, f m} and k ∈ {pm, f m}. Solving for the output sym-
bol probabilities p (Ok ) we get, p (Opm ) = p11pi + (1 − p22)pp , and
p (Of m ) = (1 − p11)pi + p22pp + pf . The transition matrix for the
channel is expressed as:
P =

p11 1 − p11
1 − p22 p22
0 1

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The mutual information is obtained as follows:
I (V ;O ) =
∑
o∈O,v ∈V
p(V ,O ) (v,o) log
(
p(V ,O ) (v,o)






loд((1 − p22)pp )−(




(1 − p11)pi + p22pp + pf
)
+p11pi loд(p11) + p12pi loд(p21) + p21pploд(p12)
+p22pploд(p22)
(17)
The information-theoretic capacity of the channel with virus at the
transmitter V and virus at the receiver O , which is defined as the
maximum mutual information I (V ;O ) over the symbol probability
pv ∈ (pi , pp , pf ), is given by:
C = max
pv
I (V ;O ) (18)
where pi , pp , and pf are the injection probabilities of different set of
virus at the transmitter.
5 NUMERICAL ANALYSIS
We performed in-silico experiments to evaluate the channel per-
formance in terms of signal transmission, attenuation along the
channel, and capacity of the channel. The Python-based simulations
are carried out to numerically solve the set of ordinary differential
equations defining the proposed channel. The values against the
parameters used in the simulation, which are collected from the
existing literature [5, 22, 23] are listed in Table 1. In each simulation,
a set of 104 virus (the value commonly taken for DENV based exper-
iment [11]) and 100 susceptible cells in the vicinity are considered
in a confined area. In the modeled channel, the time considered is in
days depicting the transmission of the dengue virus (signal).
Table 1: Simulation Parameters
Parameter Value
Growth rate of susceptible cells (α ) 10
Transition rate of cells (β ) 1
Predation rate of virus (φ ) 0.002
Replication rate of virus (γ ) 20
Production rate of immune proteins (ai ) 4
Production rate of immune cells (ac ) 10
Production rate of antibodies (η) 15
The variation of signal strength during the transmission along
the channel is shown in Fig. 5. We estimated the endocytic rate and
engulfing capacity to be 0.8 and 1, respectively, while the death rate
of the virus was estimated to be 300 concerning the initial injection
of 104 virus particles. It was observed that initially, the concentra-
tion increases and then reaches a fixed value, which is referred to
as equilibrium. However, the concentration of host cells shows a
contrasting behavior. As the virus continues invading susceptible
host cells, the concentration of host cells decreases and then gradu-
ally tends to increase with the onset of the immune response. The
frequency-domain representation of the signal (combination of im-
mature, partially mature, and fully mature virus at injection time)
is shown in Fig. 6. The signal strength refers to the concentration
of virus particles along the channel over the time period measured
in days. It was noted that the signal strength decreased gradually
Figure 5: Variation of the mature virus in the channel.
Figure 6: Power spectrum of the virus (immature, partially
mature, and fully mature).
Figure 7: Variation of signal strength (concentration of virus)
and attenuation.
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Figure 8: Capacity as a function of symbol probabilities.
with time due to the rapid increase in immune response in both the
channels, resulting in the attenuation of the signal, as shown in Fig.
7. It was also observed that in the cutaneous channel, the signal
attenuates in the initial period following injection, while the signal
attenuates more in a later time in the vascular channel. The signal
(concentration of virus particles) is stronger initially when the value
is close to zero in a negative dB scale. The higher the attenuation
value, the more the likelihood of degradation in signal strength. Fig.
8 shows the trend of the channel capacity with the variation of the
symbol probabilities with which the virus particles get injected inside
the human body. It was observed that the value of channel capacity
reaches the maximum when the condition of symbol probabilities,
pi < pp < pf , holds. The influence of Vf m is found to be greater
than its counterparts (Vim and Vpm ) at the receiver. Since all the
input symbol has equal probability for pi = pp = pf , the capacity is
restrained at one point.
6 CONCLUSION
In this work, we proposed an end-to-end communication system
for DENV proliferation inside a human body. The modeling and
analyses provide crucial information on the change in the profile of
the virus during their transmission, which plays a key role for the
development of novel mechanisms to stop the spread of the dengue
virus. We evaluated the proposed channel model by showing the
variation of different channel characteristics with time such as atte-
nuation, signal strength, and the channel capacity. In the future, we
intend to explore the impact of time-varying channel conditions on
the achievable maximum rate. We also plan to include noise that
the channel encounters in the fluidic environment in order to get an
in-depth insight into the DENV proliferation inside the body.
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